{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T14:31:26Z","timestamp":1791469886562,"version":"4.3.4"},"reference-count":30,"publisher":"Oxford University Press (OUP)","issue":"9","license":[{"start":{"date-parts":[[2022,1,10]],"date-time":"2022-01-10T00:00:00Z","timestamp":1641772800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,8,30]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Objective<\/jats:title>\n                  <jats:p>This study analysed the very early disease of SSc (VEDOSS) characteristics in a group of 217 patients with RP and at least one manifestation of SSc in search of predictors for the progression to SSc.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>This was a cross-sectional single-centre analysis of patients presenting with RP with a specific SSc clinical manifestation or SSc autoantibody or SD pattern at nailfold capillaroscopy (SD-NFC), without skin involvement, who attended a scleroderma outpatient clinic between 2010 and 2019. The performance of VEDOSS and the importance of the combination of VEDOSS characteristics to predict the progression to SSc were evaluated.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Among 217 patients, 153 (70.5%) were classified as SSc, including 65 (30%) in the first investigation; 69.3% of the SSc patients met VEDOSS criteria compared with 6.3% of patients who did not progress to SSc. The combinations most associated with progression to SSc were RP\u2009+\u2009puffy fingers (PF) +\u2009positive ANA\u2009+\u2009SD-NFC and\/or SSc-specific antibody (VEDOSS level 2), with an odds ratio (OR) of 19.52 (95% CI 4.48, 85.06; P\u2009&amp;lt;\u20090.001) and RP\u2009+\u2009PF\u2009+\u2009positive ANA (VEDOSS level 1; \u2018red flags\u2019) (OR 15.45; P\u2009&amp;lt;\u20090.001), while combinations without non-RP clinical symptoms, as RP\u2009+\u2009SD-NFC (OR 0.03; P\u2009&amp;lt;\u20090.001) and RP\u2009+\u2009anticentromere\u2009+\u2009SD-NFC (OR 0.06; P\u2009=\u20090.006) were associated with non-progression to SSc.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>Among patients with RP with at least one manifestation of SSc, without skin involvement, combinations of VEDOSS characteristics were the strongest predictors of progression to SSc at a median follow-up of 4\u2009years.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/rheumatology\/keac006","type":"journal-article","created":{"date-parts":[[2022,1,7]],"date-time":"2022-01-07T12:14:11Z","timestamp":1641557651000},"page":"3686-3692","source":"Crossref","is-referenced-by-count":22,"title":["Predictors of progression to systemic sclerosis: analysis of very early diagnosis of systemic sclerosis in a large single-centre cohort"],"prefix":"10.1093","volume":"61","author":[{"given":"Valdirene S","family":"Siqueira","sequence":"first","affiliation":[{"name":"Division of Rheumatology, Hospital das Cl\u00ednicas HCFMUSP, Faculdade de Medicina da Universidade de S\u00e3o Paulo , S\u00e3o Paulo, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariely F S","family":"Helbingen","sequence":"additional","affiliation":[{"name":"Division of Rheumatology, Hospital das Cl\u00ednicas HCFMUSP, Faculdade de Medicina da Universidade de S\u00e3o Paulo , S\u00e3o Paulo, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana Cristina","family":"Medeiros-Ribeiro","sequence":"additional","affiliation":[{"name":"Division of Rheumatology, Hospital das Cl\u00ednicas HCFMUSP, Faculdade de Medicina da Universidade de S\u00e3o Paulo , S\u00e3o Paulo, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henrique","family":"Carri\u00e7o da Silva","sequence":"additional","affiliation":[{"name":"Division of Rheumatology, Hospital das Cl\u00ednicas HCFMUSP, Faculdade de Medicina da Universidade de S\u00e3o Paulo , S\u00e3o Paulo, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renata","family":"Miossi","sequence":"additional","affiliation":[{"name":"Division of Rheumatology, Hospital das Cl\u00ednicas HCFMUSP, Faculdade de Medicina da Universidade de S\u00e3o Paulo , S\u00e3o Paulo, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana Paula","family":"Luppino-Assad","sequence":"additional","affiliation":[{"name":"Division of Rheumatology, Hospital das Cl\u00ednicas HCFMUSP, Faculdade de Medicina da Universidade de S\u00e3o Paulo , S\u00e3o Paulo, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9843-6686","authenticated-orcid":false,"given":"Percival D","family":"Sampaio-Barros","sequence":"additional","affiliation":[{"name":"Division of Rheumatology, Hospital das Cl\u00ednicas HCFMUSP, Faculdade de Medicina da Universidade de S\u00e3o Paulo , S\u00e3o Paulo, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2022,1,10]]},"reference":[{"key":"2022090108144895500_keac006-B1","first-page":"1573","article-title":"Criteria for the classification of early systemic sclerosis","volume":"28","author":"LeRoy","year":"2001","journal-title":"J Rheumatol"},{"key":"2022090108144895500_keac006-B2","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1002\/1529-0131(200002)43:2<444::AID-ANR27>3.0.CO;2-G","article-title":"Systemic sclerosis sine scleroderma: demographic, clinical, and serologic features and survival in forty-eight patients","volume":"43","author":"Poormoghim","year":"2000","journal-title":"Arthritis Rheum"},{"key":"2022090108144895500_keac006-B3","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1136\/ard.2008.106302","article-title":"The challenge of early systemic sclerosis for the EULAR Scleroderma Trial and Research group (EUSTAR) community. It is time to cut the Gordian knot and develop a prevention or rescue strategy","volume":"68","author":"Matucci-Cerinic","year":"2009","journal-title":"Ann Rheum Dis"},{"key":"2022090108144895500_keac006-B4","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1136\/annrheumdis-2013-204424","article-title":"2013 classification criteria for systemic sclerosis: an American College of Rheumatology\/European League Against Rheumatism collaborative initiative","volume":"72","author":"van den Hoogen","year":"2013","journal-title":"Ann Rheum Dis"},{"key":"2022090108144895500_keac006-B5","doi-asserted-by":"crossref","first-page":"2737","DOI":"10.1002\/art.38098","article-title":"2013 classification criteria for systemic sclerosis: an American College of Rheumatology\/European League Against Rheumatism collaborative initiative","volume":"65","author":"van den Hoogen","year":"2013","journal-title":"Arthritis Rheum"},{"key":"2022090108144895500_keac006-B6","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1136\/ard.2010.136929","article-title":"Preliminary criteria for the very early diagnosis of systemic sclerosis: results of a Delphi Consensus Study of the EULAR Scleroderma Trial and Research group","volume":"70","author":"Avouac","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"2022090108144895500_keac006-B7","doi-asserted-by":"crossref","first-page":"101474","DOI":"10.1016\/j.berh.2019.101474","article-title":"Raynaud\u2019s phenomenon","volume":"34","author":"Herrick","year":"2020","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"2022090108144895500_keac006-B8","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1093\/rheumatology\/kep447","article-title":"Improving outcome prediction of systemic sclerosis from isolated Raynaud\u2019s phenomenon: role of autoantibodies and nail-fold capillaroscopy","volume":"49","author":"Ingegnoli","year":"2010","journal-title":"Rheumatology (Oxford)"},{"key":"2022090108144895500_keac006-B9","doi-asserted-by":"crossref","first-page":"e834","DOI":"10.1016\/S2665-9913(21)00244-7","article-title":"Progression of patients with Raynaud\u2019s phenomenon to systemic sclerosis: a five-year analysis of the European Scleroderma Trial and Research group multicentre, longitudinal registry study for Very Early Diagnosis of Systemic Sclerosis (VEDOSS","volume":"3","author":"Bellando-Randone","year":"2021","journal-title":"Lancet Rheumatol"},{"key":"2022090108144895500_keac006-B10","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1136\/annrheumdis-2011-200742","article-title":"Update on the profile of the EUSTAR cohort: an analysis of the EULAR Scleroderma Trial and Research group database","volume":"71","author":"Meier","year":"2012","journal-title":"Ann Rheum Dis"},{"key":"2022090108144895500_keac006-B11","doi-asserted-by":"crossref","first-page":"82","DOI":"10.3899\/jrheum.190976","article-title":"The challenge of very early systemic sclerosis: a combination of mild and early disease?","volume":"48","author":"Blaja","year":"2021","journal-title":"J Rheumatol"},{"key":"2022090108144895500_keac006-B12","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/s41927-021-00209-z","article-title":"The frequency of Raynaud\u2019s phenomenon, very early diagnosis of systemic sclerosis, and systemic sclerosis in a large Veteran Health Administration database","volume":"5","author":"Frech","year":"2021","journal-title":"BMC Rheumatol"},{"key":"2022090108144895500_keac006-B13","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1136\/annrheumdis-2013-203716","article-title":"Preliminary analysis of the very early diagnosis of systemic sclerosis (VEDOSS) EUSTAR multicentre study: evidence for puffy fingers as a pivotal sign for suspicion of systemic sclerosis","volume":"73","author":"Minier","year":"2014","journal-title":"Ann Rheum Dis"},{"key":"2022090108144895500_keac006-B14","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/0002-9343(82)90846-4","article-title":"A prospective study of Raynaud phenomenon and early connective tissue disease. A five-year report","volume":"72","author":"Harper","year":"1982","journal-title":"Am J Med"},{"key":"2022090108144895500_keac006-B15","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1002\/art.1780280114","article-title":"Evolution of primary Raynaud\u2019s phenomenon (Raynaud\u2019s disease) to connective tissue disease","volume":"28","author":"Gerbracht","year":"1985","journal-title":"Arthritis Rheum"},{"key":"2022090108144895500_keac006-B16","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/0002-9343(87)90760-1","article-title":"How to classify Raynaud\u2019s phenomenon: long-term follow-up study of 73 cases","volume":"83","author":"Priollet","year":"1987","journal-title":"Am J Med"},{"key":"2022090108144895500_keac006-B17","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1136\/ard.47.8.634","article-title":"Development of connective tissue disease in patients presenting with Raynaud\u2019s phenomenon: a six-year follow-up with emphasis on the predictive value of antinuclear antibodies as detected by immunoblotting","volume":"47","author":"Kallenberg","year":"1988","journal-title":"Ann Rheum Dis"},{"key":"2022090108144895500_keac006-B18","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1001\/archinte.158.6.595","article-title":"Outcomes in primary Raynaud phenomenon: a meta-analysis of the frequency, rates, and predictors of transition to secondary diseases","volume":"158","author":"Spencer-Green","year":"1998","journal-title":"Arch Intern Med"},{"key":"2022090108144895500_keac006-B19","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1093\/rheumatology\/keu296","article-title":"Digital ulcers as a sentinel sign for early internal organ involvement in very early systemic sclerosis","volume":"54","author":"Bruni","year":"2015","journal-title":"Rheumatology (Oxford)"},{"key":"2022090108144895500_keac006-B20","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1002\/art.37988","article-title":"Evidence that systemic sclerosis is a vascular disease","volume":"65","author":"Matucci-Cerinic","year":"2013","journal-title":"Arthritis Rheum"},{"key":"2022090108144895500_keac006-B21","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1093\/rheumatology\/ket163","article-title":"Systemic sclerosis sine scleroderma: distinct features in a large Brazilian cohort","volume":"52","author":"Marangoni","year":"2013","journal-title":"Rheumatology (Oxford)"},{"key":"2022090108144895500_keac006-B22","first-page":"124","article-title":"Evidence for oesophageal and anorectal involvement in very early systemic sclerosis (VEDOSS): report from a single VEDOSS\/EUSTAR centre","volume":"74","author":"Bruni","year":"2014","journal-title":"Ann Rheum Dis"},{"key":"2022090108144895500_keac006-B23","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1183\/13993003.00150-2015","article-title":"An official European Respiratory Society\/American Thoracic Society research statement: interstitial pneumonia with autoimmune features","volume":"46","author":"Fischer","year":"2015","journal-title":"Eur Respir J"},{"key":"2022090108144895500_keac006-B24","first-page":"3009","article-title":"Autoantibodies and microvascular damage are independent predictive factors for the progression of Raynaud\u2019s phenomenon to systemic sclerosis. A twenty-year prospective study of 586 patients, with validation of proposed criteria for early systemic sclerosis","volume":"58","author":"Koenig","year":"2009","journal-title":"Arthritis Rheum"},{"key":"2022090108144895500_keac006-B25","first-page":"82","article-title":"From VEDOSS to established systemic sclerosis diagnosis according to ACR\/EULAR 2013 classification criteria: a French-Italian capillaroscopic survey","volume":"36","author":"Vasile","year":"2018","journal-title":"Clin Exp Rheumatol"},{"key":"2022090108144895500_keac006-B26","doi-asserted-by":"crossref","DOI":"10.1093\/rheumatology\/keab668","article-title":"Causes of Raynaud\u2019s phenomenon and the predictive laboratory and capillaroscopy features for the evolution to a definite connective tissue disease","volume":"61","author":"Shenavandeh","year":"2022","journal-title":"Rheumatology (Oxford)"},{"key":"2022090108144895500_keac006-B27","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1186\/s12891-016-1206-5","article-title":"Absence of scleroderma pattern at nailfold capillaroscopy is valuable in the exclusion of scleroderma in unselected patients with Raynaud\u2019s phenomenon","volume":"17","author":"Bissell","year":"2016","journal-title":"BMC Musculoskelet Disord"},{"key":"2022090108144895500_keac006-B28","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.3899\/jrheum.111582","article-title":"Survival, causes of death, and prognostic factors in systemic sclerosis: analysis of 947 Brazilian patients","volume":"39","author":"Sampaio-Barros","year":"2012","journal-title":"J Rheumatol"},{"key":"2022090108144895500_keac006-B29","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s10067-019-04575-5","article-title":"Clinical and laboratory features of African-Brazilian patients with systemic sclerosis","volume":"39","author":"Mendes","year":"2020","journal-title":"Clin Rheumatol"},{"key":"2022090108144895500_keac006-B30","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1177\/2397198319869564","article-title":"Prediction of organ involvement and survival in systemic sclerosis patients in the first 5 years from diagnosis","volume":"5","author":"van den Hombergh","year":"2020","journal-title":"J Scleroderma Relat Dis"}],"container-title":["Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/rheumatology\/advance-article-pdf\/doi\/10.1093\/rheumatology\/keac006\/42267991\/keac006.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/rheumatology\/article-pdf\/61\/9\/3686\/45626831\/keac006.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/rheumatology\/article-pdf\/61\/9\/3686\/45626831\/keac006.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T08:36:21Z","timestamp":1662021381000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/rheumatology\/article\/61\/9\/3686\/6502299"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,10]]},"references-count":30,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2022,1,10]]},"published-print":{"date-parts":[[2022,8,30]]}},"URL":"https:\/\/doi.org\/10.1093\/rheumatology\/keac006","relation":{},"ISSN":["1462-0324","1462-0332"],"issn-type":[{"value":"1462-0324","type":"print"},{"value":"1462-0332","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2022,9,1]]},"published":{"date-parts":[[2022,1,10]]}}}